» Articles » PMID: 29032429

DNA Damage and Oxidative Stress Induced by Seizures Are Decreased by Anticonvulsant and Neuroprotective Effects of Lobeline, a Candidate to Treat Alcoholism

Abstract

The alkaloid lobeline (Lob) has been studied due to its potential use in treatment of drug abuse. This study evaluates the possible anticonvulsant and neuroprotective activities of Lob to obtain new information on its properties that could confirm it as a candidate in the treatment of alcohol addiction. The anticonvulsant effect of Lob was evaluated using a pilocarpine-induced seizure model. In addition, possible neuroprotective effects were investigated measuring DNA damage using the comet assay, assessing free radical levels by dichlorofluorescein diacetate (DCF) oxidation, and measuring the antioxidant potential using the α, α-diphenyl-β-picrylhydrazyl (DPPH) scavenging assay, besides measuring superoxide dismutase (SOD) and catalase (CAT) enzyme activities in brain tissues. Lobeline increased the latency to the first seizure and decreased the percentage of seizures in a similar way as diazepam, used as control. DNA damage induced by Pil and hydrogen peroxide were decreased in hippocampus and cerebral cortex from mice treated with Lob. The levels of free radicals and CAT activity increased in cortex and hippocampus, respectively, in mice treated with Pil. Lobeline decreased CAT in hippocampus, leading to similar values as in the saline negative control. In conclusion, Lob has anticonvulsant and neuroprotective actions that may be mediated by antioxidant-like mechanisms, indicating its potential as candidate drug in alcoholism therapy.

Citing Articles

CNEURO-201, an Anti-amyloidogenic Agent and σ1-Receptor Agonist, Improves Cognition in the Mouse Model of Alzheimer's Disease by Multiple Actions in the Pathology.

Martinez-Orozco H, Bencomo-Martinez A, Maya-Arteaga J, Rubio-De Anda P, Sanabria-Romero F, Casas Z Int J Mol Sci. 2025; 26(3).

PMID: 39941068 PMC: 11818425. DOI: 10.3390/ijms26031301.


Corinthian Currants Promote the Expression of Paraoxonase-1 and Enhance the Antioxidant Status in Serum and Brain of 5xFAD Mouse Model of Alzheimer's Disease.

Lymperopoulos D, Dedemadi A, Voulgari M, Georgiou E, Dafnis I, Mountaki C Biomolecules. 2024; 14(4).

PMID: 38672443 PMC: 11047902. DOI: 10.3390/biom14040426.


Geniposide and asperuloside alter the COX-2 and GluN2B receptor expression after pilocarpine-induced seizures in mice.

Uczay M, Pfluger P, Picada J, de Oliveira J, da SilvaTorres I, Medeiros H Naunyn Schmiedebergs Arch Pharmacol. 2022; 396(5):951-962.

PMID: 36536207 DOI: 10.1007/s00210-022-02367-4.


Alcohol-Induced Oxidative Stress and the Role of Antioxidants in Alcohol Use Disorder: A Systematic Review.

Tsermpini E, Plemenitas Iljes A, Dolzan V Antioxidants (Basel). 2022; 11(7).

PMID: 35883865 PMC: 9311529. DOI: 10.3390/antiox11071374.


Beyond Alkaloids: Novel Bioactive Natural Products From Species.

Zheng Q, Wang Y, Zhang S Front Pharmacol. 2021; 12:638210.

PMID: 33762957 PMC: 7982472. DOI: 10.3389/fphar.2021.638210.


References
1.
Qiu X, Cao L, Yang X, Zhao X, Liu X, Han Y . Role of mitochondrial fission in neuronal injury in pilocarpine-induced epileptic rats. Neuroscience. 2013; 245:157-65. DOI: 10.1016/j.neuroscience.2013.04.019. View

2.
Lambe E, Picciotto M, Aghajanian G . Nicotine induces glutamate release from thalamocortical terminals in prefrontal cortex. Neuropsychopharmacology. 2003; 28(2):216-25. DOI: 10.1038/sj.npp.1300032. View

3.
Dwoskin L, Crooks P . A novel mechanism of action and potential use for lobeline as a treatment for psychostimulant abuse. Biochem Pharmacol. 2002; 63(2):89-98. DOI: 10.1016/s0006-2952(01)00899-1. View

4.
Gravielle M . Activation-induced regulation of GABAA receptors: Is there a link with the molecular basis of benzodiazepine tolerance?. Pharmacol Res. 2016; 109:92-100. DOI: 10.1016/j.phrs.2015.12.030. View

5.
Turski L, Ikonomidou C, Turski W, Bortolotto Z, Cavalheiro E . Review: cholinergic mechanisms and epileptogenesis. The seizures induced by pilocarpine: a novel experimental model of intractable epilepsy. Synapse. 1989; 3(2):154-71. DOI: 10.1002/syn.890030207. View